Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer

Area of Science:

• Immunology
• Oncology
• Single-cell biology

Background:

• Cancer-associated fibroblasts (CAFs), specifically FAP+ CAF-S1 subtypes, are known to mediate immunosuppression in breast cancers.
• The heterogeneity of these CAFs and their precise impact on immunotherapy response remain largely unknown.

Purpose of the Study:

• To characterize the heterogeneity of FAP+ CAF-S1 fibroblasts at a single-cell level.
• To identify specific CAF subtypes associated with immunosuppression and resistance to cancer immunotherapy.
• To elucidate the mechanisms underlying CAF-mediated immune evasion and immunotherapy resistance.

Main Methods:

• Analysis of over 19,000 single CAF-S1 fibroblasts from breast cancer using single-cell sequencing.
• Validation of key CAF-S1 clusters via flow cytometry and in silico analyses across multiple cancer types.
• Investigation of molecular interactions between CAF subtypes and immune cells, including regulatory T lymphocytes (Tregs).

Main Results:

• Identification of 8 distinct CAF-S1 clusters, with 5 validated across cancer types.
• Specific myofibroblast clusters (Cluster 0/ecm-myCAF and Cluster 3/TGFβ-myCAF) were associated with primary resistance to immunotherapies.
• A positive feedback loop was identified where Cluster 0 upregulates PD-1 and CTLA-4 on Tregs, which in turn promotes the expansion of Cluster 3.

Conclusions:

• Specific FAP+ CAF-S1 subtypes play a critical role in mediating tumor immunosuppression and immunotherapy resistance.
• The identified feedback loop between specific CAF-S1 clusters and Tregs contributes to immune evasion.
• Understanding these distinct CAF signatures offers potential therapeutic strategies to enhance immunotherapy efficacy.